67Ga scintigraphy: Procedure guidelines for tumour imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 12, 2003, Pages

  Bombardieri, Emilio ^a   Aktolun, Cumali ^b   Baum, Richard P ^c   Bishof Delaloye, Angelika ^d   Buscombe, John ^e   Chatal, Jean François ^f   Maffioli, Lorenzo ^g   Moncayo, Roy ^h   Mortelmans, Luc ⁱ   Reske, Sven N ^j  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b KOCAELI UNIVERSITY   (Turkey)

^c PET Center   (Germany)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g A MANZONI HOSPITAL   (Italy)

^h UNIVERSITY OF INNSBRUCK   (Austria)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j UNIVERSITY OF ULM   (Germany)

more..

Author keywords

67Ga scintigraphy; Indications; Procedure guidelines; Tumour Imaging

Indexed keywords

GADOLINIUM; CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; IMAGE PROCESSING; LYMPHOMA; ONCOLOGY; PRACTICE GUIDELINE; RADIATION DOSE; REVIEW; SCINTIGRAPHY; SCINTILLATION CAMERA; TECHNIQUE; ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EUROPE; HUMAN; MEDICAL SOCIETY; METHODOLOGY; NEOPLASM; NUCLEAR MEDICINE; PATIENT CARE; SCINTISCANNING; STANDARD;

CITRATES; EUROPE; GALLIUM; HUMANS; NEOPLASMS; NUCLEAR MEDICINE; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; SOCIETIES, MEDICAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0347995057     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1356-1     Document Type: Review

References (45)

1. Bar-Shalom R, Mor M, Yefremov N, Goldsmith SJ. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose position emission tomography in staging and monitoring the response of lymphoma to treatment. Semin Nucl Med 2001; 31:177-190.
2. Bartold SP, Donohoe KJ, Fletcher JW, et al. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med 1997; 38:990-994.
3. Becherer A, Jaeger U, Szabo M, Kletter K. Prognostic value of FDG-PET in malignant lymphoma. Q J Nucl Med 2003; 47:14-21.
4. Ben-Haim S, Bar-Shalom R, Israel O, et al. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1996; 14:1936-1942.
5. Brenot-Rossi I, Bouabdallah R, Di Stefano D, et al. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy. Eur J Nucl Med 2001; 28:1482-1488.
6. Castellani MR, Cefalo G, Terenziani M, et al. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value. Q J Nucl Med 2003; 47:22-30.
7. Chajari M, Lacroix J, Peny AM, et al. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with CT? Eur J Nucl Med Mol Imaging 2002; 29:380-387.
8. Coiffier B. Positron emission tomography and gallium metabolic imaging in lymphoma. Curr Oncol Rep 2001; 3:266-270.
9. Delcambre C, Reman O, Henry-Amar M, et al. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy. Eur J Nucl Med 2000; 27:176-184.
10. DeRoqatis AJ, Ramos J, Depurey EG. Accuracy of early gallium imaging in diagnosis of pulmonary infection in immunocompromised patients. J Nucl Med 1992; 33:957.
11. Devizzi L, Maffioli L, Bonfante V, et al. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease. Ann Oncol 1997; 8:53-56.
12. Draisma A, Maffioli L, Gasparini M, Savelli G, Pauwels E, Bombardieri E. Gallium-67 as a tumor-seeking agent in lymphomas - a review. Tumori 1998; 84:434-441.
13. Even-Sapir E, Israel O. Gallium-67 scintigraphy: a corner-stone in functional imaging lymphoma. Eur J Nucl Med Mol Imaging 2003; 30:S65-S81.
14. Front D, Isreal O. Present state and future role of gallium 67 scintigraphy in lymphoma. J Nucl Med 1996; 37:530-532.
15. Front D, Bar-Shalom R, Israel O, et al. The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging. Semin Nucl Med 1997; 27:68-74.
16. 67Ga scintigraphy after one cycle of chemotherapy. Radiology 1999; 210:487-491.
17. 67Ga scintigraphy. Radiology 2000; 214:253-257.
18. Gallamini A, Biggi A, Fruttero A, et al. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma. Eur J Nucl Med 1997; 24:1499-1506.
19. Gasparini M, Bombardieri E, Castellani M, et al. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma. J Nucl Med 1998; 39:1586-1590.
20. Hussain R, Christie DR, Gebski V, et al. The role of the gallium scan in primary extranodal lymphoma. J Nucl Med 1998; 39:95-98.
21. ICRP Publication 53. Radiation dose to patients from radiopharmaceuticals. Ann ICRP 1987; 18:1-4.
22. ICRP Publication 62. Radiological protection in biomedical research. Ann ICRP 1991; 22:3.
23. ICRP Publication 80. Radiation dose to patients from radiopharmaceuticals. Ann ICRP 1998; 28:3.
24. Israel O, Jemshalmi J, Ben-Haim S, et al. Normal and abnormal Ga-67 SPECT anatomy in patients with lymphoma. Clin Nucl Med 1990; 15:334-345.
25. 67Ga scintigraphy and CT for prediction of outcome after treatment. J Nucl Med 2002; 43:1295-1303.
26. Janicek M, Kaplan W, Neuberg D, et al. Restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol 1997; 15:1631-1637.
27. Kao PF, Tsui KH, Leu HS, et al. Diagnosis and treatment of pyrogenic psoas abscess in diabetic patients: usefulness of computed tomography and gallium-67 scanning. Urology 2001; 57:246-251.
28. Kostakoglu L, Goldsmith SJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med 2000; 27:1564-1578.
29. 18F-fluorodeoxyglucose PET and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002; 15:879-888.
30. Larson SM, Hoffer PB. Normal patterns of localization. In: Hoffer PB, Bekerman C, Henkin RE, eds. Gallium-67 imaging. New York: John Wiley; 1978:23-28.
31. Maisey NR, Hill ME, Webb A, et al. Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses? Eur J Cancer 2000; 36:200-206.
32. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994; 24:128-141.
33. Peters AM. Localising the cause of an undiagnosed fever. Eur J Nucl Med 1996; 23:239-242.
34. Peters AM. Nuclear medicine imaging in fever of unknown origin. Q J Nucl Med 1999; 43:61-73.
35. Rehm PK. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma. Cancer Biother Radiopharm 1999; 14:251-262.
36. Salloum E, Brandt DS, Caride VJ, et al. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol 1997; 15:518-527.
37. Sasaki M, Kuwabara Y, Koga H, et al. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Ann Nucl Med 2002; 16:337-345.
38. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma. Nucl Med Commun 1997; 18:405-411.
39. Sfakianakis GN, Al-Sheikh W, Heal A, et al. Comparison of scintigraphy with In-111 leukocytes and Ga-67 in the diagnosis of occult sepsis. J Nucl Med 1982; 23:618-626.
40. Tsai SC, Chao TH, Lin WY, et al. Ga-67 scan to detect intraabdominal infections in patients after colorectal surgery. Clin Nucl Med 2001; 26:826-831.
41. Vose JM, Bierman PJ, Anderson JR, et al. Single photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1996; 14:2473-2479.
42. Waldherr C, Otte A, Mueller-Brand J. Ga-67 scintigraphy in a patient with B-cell lymphoma. Clin Nucl Med 2000; 25:389.
43. Waxman A, Eller D, Ashook G, et al. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. J Nucl Med 1996; 37:46-50.
44. Wirth A, Seymour JF, Hicks RJ, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med 2002; 112:262-268.
45. Zinzani PL, Magagnoli M, Franchi R, et al. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement. Haematologica 1999; 84:604-607.